These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 37190751

  • 21. Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.
    Maximova N, Schillani G, Simeone R, Maestro A, Zanon D.
    Adv Ther; 2017 May; 34(5):1184-1199. PubMed ID: 28429246
    [Abstract] [Full Text] [Related]

  • 22. Optimization of Micafungin Dosage for Chinese Patients with Sepsis in the Intensive Care Unit Based on a Population Pharmacokinetic-Pharmacodynamic Analysis.
    Zhong S, Zhu X, Zhao L, Song Y, Yu J, Zheng Z, Zang B.
    Pharm Res; 2021 Jan; 38(1):67-77. PubMed ID: 33404989
    [Abstract] [Full Text] [Related]

  • 23. Micafungin as antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: results of different dosage levels in clinical practice.
    Langebrake C, Rohde H, Lellek H, Wolschke C, Kröger NM.
    Clin Transplant; 2014 Mar; 28(3):286-91. PubMed ID: 24479680
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Evaluating posaconazole dosing regimens of the different formulations against Aspergillus spp. in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
    Wei XC, Zhao MF, Li X, Xiao X.
    Int J Antimicrob Agents; 2020 Oct; 56(4):106112. PubMed ID: 32721598
    [Abstract] [Full Text] [Related]

  • 32. Micafungin use in children.
    Emiroglu M.
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.
    García-de-Lorenzo A, Luque S, Grau S, Agrifoglio A, Cachafeiro L, Herrero E, Asensio MJ, Sánchez SM, Roberts JA.
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5914-21. PubMed ID: 27458229
    [Abstract] [Full Text] [Related]

  • 35. Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species.
    Zaki A, Gonzales-Luna AJ, Beyda ND, Lasco T, Garey KW.
    Pharmacotherapy; 2023 Jun; 43(6):466-472. PubMed ID: 37067155
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections.
    Scott LJ.
    Drugs; 2012 Nov 12; 72(16):2141-65. PubMed ID: 23083111
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.